Schedule 13G ownership disclosure
RETROPHIN INC
Security class unavailable · CUSIP: 761299106
Event date: 2016-03-21
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 9.8600%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000891092-16-013889
- Form type
- SC 13G
- Filer
- Travere Therapeutics, Inc.
- CIK
- CIK 1438533
- Filed
- Mar 31, 2016
- Reporting period
- Mar 21, 2016
- Description
- Schedule 13G beneficial ownership